As of Feb 05
| +0.0249 / +3.28%|
The 3 analysts offering 12-month price forecasts for Sunesis Pharmaceuticals Inc have a median target of 1.00, with a high estimate of 3.00 and a low estimate of 0.75. The median estimate represents a +27.39% increase from the last price of 0.79.
The current consensus among 5 polled investment analysts is to Buy stock in Sunesis Pharmaceuticals Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.